Q32 Bio Inc.

QTTB | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.47

-$0.07 (-0.66%)

At close: Sep 21, 2026, 4:00 PM ET

$10.98

+$0.51 (+4.85%)

Pre-market: Sep 22, 2026, 7:55 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $311.63M

Enterprise Value $209.92M

Beta -0.33

Average Volume 1.16M

Shares Outstanding (Diluted) 20.34M

Shares Change YoY 66.77%

Institutional Ownership 66.89%

Exchange NASDAQ

ISIN US7469641051

Price Performance

Price Change 1M -36.5%

Price Change 3M -11.9%

Price Change 6M 44.4%

Price Change YTD 204.4%

Price Change 1Y 459.9%

Price Change 3Y -50.3%

Price Change 5Y -93.3%

1M CAGR (ann.) -32.9%

1Y CAGR (ann.) 501.7%

5Y CAGR (ann.) -40.2%

All-Time CAGR -33.5%

Valuation

PE Ratio 3.75

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.13

PS Ratio 5.80

Forward PS 311.60

PB Ratio 2.94

P/FCF Ratio -11.91

P/Adj. FCF Ratio -9.28

P/OCF Ratio -7.43

EV/Sales 3.91

EV/EBIT 6.14

EV/EBITDA 6.06

EV/FCF -8.02

Earnings Yield 26.6%

FCF Yield -8.4%

Adj. FCF Yield -10.8%

Financial Health

Net Cash $101.71M

Total Debt $4.56M

Cash & Short-Term Investments $106.27M

Total Assets $115.87M

Current Ratio 20.30

Quick Ratio 20.30

Debt / Equity Ratio 0.05

Debt / EBITDA 0.13

Debt / FCF -0.17

OCF / Debt -5.74

Interest Coverage 16.51

Altman Z-Score 18.61

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 99.8%

Operating Profit Margin 39.9%

EBITDA Margin 64.4%

Net Profit Margin 62.9%

FCF Margin -48.7%

Adj. FCF Margin -62.5%

SBC / Revenue 10.9%

SBC Impact (per share) -28.4%

Returns

Return on Assets 29.2%

Return on Equity 76.9%

Return on Invested Capital 19.3%

Return on Capital Employed 19.4%

Return on Tangible Assets 29.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 71.1%

Revenue CAGR 5Y 10.2%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 143.9%

EPS CAGR 5Y 32.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y 7.3%

FCF CAGR 5Y 30.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y -42.6%

Revenue Growth Next 3Y 4.3%

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.36

EPS Growth Est (next Q) -40.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $21.71

Graham Upside 107.3%

Lynch Fair Value $69.75

Lynch Upside 566.2%

Price Target $38

Price Target Upside 262.9%

Cash Flow

Operating Cash Flow $-26.17M

Free Cash Flow $-26.17M

Adj. Free Cash Flow $-33.6M

FCF Per Share -$1.41

OCF Per Share -$1.41

OCF/S Ratio -36.9%

Income Statement

Revenue $53.74M

Gross Profit $53.74M

Operating Income $21.46M

EBITDA $34.62M

Net Income $33.79M

EPS (Diluted) $2.79

Revenue / Employee $2.44M

Profit / Employee $1.54M

Employees 22